C3, Equipmed sign distribution agreements
Monday, 27 October, 2003
Perth-based tissue engineering company Clinical Cell Culture (C3, ASX: CCE) has signed distribution agreements with Equipmed to distribute C3's CellSpray and ReCell products in Australia, excluding Western Australia, and New Zealand.
The ReCell agreement will be activated once TGA approval has been obtained for general marketing of the product. The agreements have three year terms and including marketing and support activities.
C3 CEO Troels Jordansen said the company was pleased to have an agreement with Equipmed, which has experience in the plastic and cosmetic surgery market and distributes tissue engineering products from international company Isolagen.
C3 is planning to expand its business internationally next year, with a European production facility in the works and sales of ReCell in 15 companies around the world expected.
Gentler form of IVF found to improve success rates
The 'soft touch' technique, known as Piezo-ICSI, works by gently penetrating an egg using...
Bird flu found in Victorian egg farm, returned traveller
Two separate instances of avian influenza (bird flu) were reported in Victoria yesterday —...
Cell-mapping project to uncover genetic fingerprints of disease
The $27m project will see researchers map 50 million human cells from 10,000 people to identify...